Westfuller Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$125K Buy
5,206
+4,402
+548% +$115K 0.05% 201
2026
Q1
$22.6K Buy
804
+104
+15% +$2.77K 0.01% 343
2025
Q4
$17.4K Buy
700
+35
+5% +$883 0.01% 388
2025
Q3
$16.9K Buy
+665
New +$16.4K 0.01% 392

Other funds holding PFE

Westfuller Advisors's PFE Position: Q2 2026 in Review

Westfuller Advisors increased its Pfizer (PFE) stake by 548% in Q2 2026, buying an estimated $115K and bringing the position to 5,206 shares worth $125K. The position accounts for 0.05% of the portfolio, ranked #201.

Westfuller Advisors first reported a position in PFE in Q3 2025 and has held it in 4 quarters since. 1,336 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Westfuller Advisors held 5,206 shares of Pfizer worth $125K as of Q2 2026.
  • Westfuller Advisors bought 4,402 Pfizer shares in Q2 2026, an estimated $115K.
  • Pfizer made up 0.05% of Westfuller Advisors's portfolio in Q2 2026, its #201 holding.
  • Westfuller Advisors first reported a position in Pfizer in Q3 2025 and has held it in 4 quarters since.
  • 1,336 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Westfuller Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.